There was a mutual exclusivity in IBC samples between alterations in the three genes (NOTCH2, NOTCH4, and CREBBP) found differentially altered in IBC vs non‐IBC, present in the KEGG NOTCH pathway, and tested in at least 30% of samples (Fig. S6). This evidence concerns the gene NOTCH2 and inflammatory breast carcinoma.